BusinessMoneycontrol
Trump’s $200-billion gamble: Replacing Indian generics will be an uphill task, say experts

in5points
Indian generics help the US save approximately $200 billion per year.
Replacing Indian generics would be an uphill task for the US, according to experts.
India's export loss from reduced generic exports may be around $10 billion.
The US would face a much larger cost than India if it attempts to replace Indian generics.
Story angle
Center-right
L
CL
C
CR
R
Mostly straight facts, with a light government- or market-friendly tilt.
About how the story is framed, not whether the facts are true.
Moneycontrol
Center-right
Mixed factuality